Literature DB >> 30961512

Novel Thiazine Substituted 9-Anilinoacridines: Synthesis, Antitumour Activity and Structure Activity Relationships.

R Kalirajan1, K Gaurav1, A Pandiselvi1, B Gowramma1, S Sankar1.   

Abstract

BACKGROUND: 9-anilinoacridines are acting as DNA-intercalating agents which plays an important role as antitumor drugs, due to their anti-proliferative properties. Some anticancer agents contain 9- anilinoacridines such as amsacrine (m-AMSA), and nitracrine (Ledakrine) have been already developed.
METHODS: In this study, novel 9-anilinoacridines substituted with thiazines 4a-r were designed, synthesized, characterized by physical and spectral data and their cytotoxic activities against DLA cell lines were evaluated.
RESULTS: Among those compounds, 4b, c, e, g, i, j, k, m, o, p, q, r exhibited significant short term in vitro cytotoxic activity against Daltons lymphoma ascites (DLA) cells with CTC50 value of 0.18 to 0.31μM. The compounds 4b, c, e, g, i, j, k, m, o, p, q, r are also exhibited significant long term in vitro anti-tumour activity against human tumor cell lines, HEp-2 (laryngeal epithelial carcinoma) by Sulforhodamine B assay with CTC50 value of 0.20 to 0.39μM. The compounds 4b, i, j exhibited significant in vivo antitumor activity with % Increase in Life Span (ILS) 48-82%.
CONCLUSION: Results obtained in this study clearly demonstrated that many of the thiazine substituted 9- anilinoacridines exert interesting anti-tumour activity. The compounds 4b, i, j have significant anti-tumour activity and useful drugs after further refinement. The above derivatives will encourage to design future antitumor agents with high therapeutic potentials. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Acridine; DLA cell lines; antitumor; in vitro activity; in vivo activity; thiazine.

Year:  2019        PMID: 30961512     DOI: 10.2174/1871520619666190408134224

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  4 in total

1.  Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach.

Authors:  Kalirajan Rajagopal; Potlapati Varakumar; Aparma Baliwada; Gowramma Byran
Journal:  Futur J Pharm Sci       Date:  2020-10-16

2.  The Discovery of Potent SHP2 Inhibitors with Anti-Proliferative Activity in Breast Cancer Cell Lines.

Authors:  Rose Ghemrawi; Mostafa Khair; Shaima Hasan; Raghad Aldulaymi; Shaikha S AlNeyadi; Noor Atatreh; Mohammad A Ghattas
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

3.  Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies.

Authors:  Kalirajan Rajagopal; Potlapati Varakumar; Baliwada Aparna; Gowramma Byran; Srikanth Jupudi
Journal:  J Biomol Struct Dyn       Date:  2020-07-28

4.  Identification of Papain-Like Protease inhibitors of SARS CoV-2 through HTVS, Molecular docking, MMGBSA and Molecular dynamics approach.

Authors:  Srikanth Jupudi; Kalirajan Rajagopal; Sankaranarayanan Murugesan; Banoth Karan Kumar; Kannan Raman; Gowramma Byran; Jayakuamar Chennaiah; Velayutham Pillai Muthiah; Bharathi Dasan P; Sathianarayanan Sankaran
Journal:  S Afr J Bot       Date:  2021-12-03       Impact factor: 2.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.